Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday
Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday
家得寶、Paysafe和3只股票在週二值得關注
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
美國股票期貨今早交易較高,以下爲可能吸引投資者關注的一些股票:
- Wall Street expects The Home Depot, Inc. (NYSE:HD) to report quarterly earnings at $4.50 per share on revenue of $43.38 billion before the opening bell, according to data from Benzinga Pro. Home Depot shares rose 0.2% to $346.59 in after-hours trading.
- RumbleOn, Inc. (NASDAQ:RMBL) reported second-quarter revenue of $22.5 million, up 27% sequentially. The revenue figure beat a Street consensus estimate of $19.69 million, according to data from Benzinga Pro. The company reported a loss of 13 cents per share, which beat a Street consensus estimate of a loss of 15 cents per share. Rumble shares fell 0.3% to close at $3.42 on Monday.
- Analysts are expecting Paysafe Limited (NYSE:PSFE) to post quarterly earnings at 8 cents per share on revenue of $424.29 million. The company will release earnings before the markets open. Paysafe shares gained 2.6% to $19.86 in after-hours trading.
- 據Benzinga Pro數據顯示,家得寶(NYSE:HD)預計在開盤前公佈每股盈利4.5美元,營業收入433.8億美元的季度業績。家得寶股價在盤後交易中上漲0.2%,至346.59美元。
- 根據Benzinga Pro的數據,Rumbleon(納斯達克:RMBL)報告第二季度營收達到2250萬美元,按季環比增長27%。營業收入數字超過了華爾街共識預期1969萬美元。該公司報告虧損13美分每股,超過了華爾街共識預期的每股虧損15美分。Rumbleon股票在週一收盤時下跌0.3%,報3.42美元。
- 分析師們預期支付領先(紐交所:PSFE)將公佈每股盈利8美分,營業收入爲42429萬美元。該公司將在市場開盤前發佈業績。支付領先股票在盤後交易中上漲2.6%,至19.86美元。
Check out our premarket coverage here
請查看我們的盤前報道。
- Kyverna Therapeutics, Inc. (NASDAQ:KYTX) said it received U.S. FDA RMAT designation for KYV-101 in the treatment of progressive myasthenia gravis. Kyverna Therapeutics shares gained 2.9% to $6.72 in the after-hours trading session.
- Analysts expect XP Inc. (NASDAQ:XP) to post quarterly earnings at 36 cents per share on revenue of $770.39 million after the closing bell. XP shares fell 0.2% to close at $18.03 on Monday.
- Kyverna Therapeutics(納斯達克:KYTX)宣佈,其產品KYV-101獲得美國FDA RMAt激勵資格,用於治療漸進性重症肌無力症。Kyverna Therapeutics股票在盤後交易中上漲2.9%,至6.72美元。
- 分析師們預計XP股份有限公司(納斯達克:XP)公佈業績,每股盈利36美分,營業收入77039萬美元。XP股價在週一收盤時下跌0.2%,報18.03美元。
- $1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
- $170萬投注於標準生物工具?看看這3只股票吧,內部人士正在積極購買。
Photo courtesy: Shutterstock
圖片來源:shutterstock